Indigenous-specific primary health care: PI19a-Number of Indigenous regular clients with a selected chronic disease who have a kidney function result within a specified category, June 2022
Indicator Attributes
Identifying and definitional attributes | |
Metadata item type: | Indicator |
---|---|
Indicator type: | Output measure |
Short name: | PI19a-Number of Indigenous regular clients with a selected chronic disease who have a kidney function result within a specified category, June 2022 |
METEOR identifier: | 772338 |
Registration status: | Indigenous, Superseded 27/08/2023 |
Description: | Number of Indigenous regular clients, aged 18 and over with:
whose estimated glomerular filtration rate (eGFR) and albumin/creatinine ratio (ACR) recorded within the previous 12 months was categorised as:
|
Rationale: | Indigenous Australians have very high levels of kidney disease due to a range of risk factors and antecedents. Kidney disease contributes substantially to the high burden of ill health experienced by Indigenous Australians. Tests of a person’s urine and blood can identify most cases of chronic kidney disease when the disease is in its early stages, enabling treatment to prevent or slow down the progression. eGFR and ACR are accepted as the best measures of kidney disease. |
Indicator set: | Indigenous-specific primary health care national key performance indicators June 2022 Indigenous, Superseded 27/08/2023 |
Collection and usage attributes | |
Population group age from: | 18 years and over. |
---|---|
Computation description: | Number of Indigenous regular clients aged 18 and over with:
who had both an eGFR (mL/min/1.73m²) and an ACR (mg/mmol) result recorded within the previous 12 months categorised as:
OR
OR
OR
OR
Presented as a number. Count is of people, not tests. Consider only the most recent eGFR and ACR tests. Calculated separately for the specified chronic disease and risk categories. Clients must have both a valid eGFR and a valid ACR test recorded to be included in this indicator. It is acknowledged that this will undercount those with high risk who could be classified based on the result of either an eGFR or an ACR test. Valid test result recorded: A valid test result is a numeric value that can be used to classify test results into the specified risk categories. Negative, non-numerical and null values are not considered to be valid results. It is acknowledged that inclusion of only valid test results may undercount the number of tests that were conducted, for example, because of known issues with pathology recording and uploading. Kidney function tests result: Categorisation refers to the risk of progressing to end stage kidney disease and the need for kidney replacement therapy (for example, dialysis or transplantation). Type 2 diabetes AND/OR CVD includes clients with:
Count clients with either or both of these conditions once only. For example, count a client with both type 2 diabetes and CVD once, not twice. |
Computation: | Numerator only. |
Numerator: | Calculation A: Number of Indigenous regular clients aged 18 and over with type 2 diabetes who had both an eGFR and an ACR result recorded within the previous 12 months which indicated normal risk. Calculation B: Number of Indigenous regular clients aged 18 and over with type 2 diabetes who had both an eGFR and an ACR result recorded within the previous 12 months which indicated low risk. Calculation C: Number of Indigenous regular clients aged 18 and over with type 2 diabetes who had both an eGFR and an ACR result recorded within the previous 12 months which indicated moderate risk. Calculation D: Number of Indigenous regular clients aged 18 and over with type 2 diabetes who had both an eGFR and an ACR result recorded within the previous 12 months which indicated high risk. Calculation E: Number of Indigenous regular clients aged 18 and over with CVD who had both an eGFR and an ACR result recorded within the previous 12 months which indicated normal risk. Calculation F: Number of Indigenous regular clients aged 18 and over with CVD who had both an eGFR and an ACR result recorded within the previous 12 months which indicated low risk. Calculation G: Number of Indigenous regular clients aged 18 and over with CVD who had both an eGFR and an ACR result recorded within the previous 12 months which indicated moderate risk. Calculation H: Number of Indigenous regular clients aged 18 and over with CVD who had both an eGFR and an ACR result recorded within the previous 12 months which indicated high risk. Calculation I: Number of Indigenous regular clients aged 18 and over with type 2 diabetes AND/OR CVD who had both an eGFR and an ACR result recorded within the previous 12 months which indicated normal risk. Calculation J: Number of Indigenous regular clients aged 18 and over with type 2 diabetes AND/OR CVD who had both an eGFR and an ACR result recorded within the previous 12 months which indicated low risk. Calculation K: Number of Indigenous regular clients aged 18 and over with type 2 diabetes AND/OR CVD who had both an eGFR and an ACR result recorded within the previous 12 months which indicated moderate risk. Calculation L: Number of Indigenous regular clients aged 18 and over with type 2 diabetes AND/OR CVD who had both an eGFR and an ACR result recorded within the previous 12 months which indicated high risk. |
Numerator data elements: | |
Disaggregation: | 1. Sex: |
Disaggregation data elements: | |
Comments: | Census date for reporting is 30 June 2022. |
Representational attributes | |
Representation class: | Count |
Data type: | Real |
Unit of measure: | Person |
Format: | N[N(6)] |
Indicator conceptual framework | |
Framework and dimensions: | Effective/Appropriate/Efficient |
Data source attributes | |
Data sources: | |
Accountability attributes | |
Reporting requirements: | Funding agreements between the Department of Health (DoH) and the organisations funded under the Indigenous Australians' Health Programme (IAHP). |
Organisation responsible for providing data: | Indigenous-specific primary health care organisations or maternal and child health programs/services funded by the DoH under its IAHP, referred to as funded organisations. |
Accountability: | Australian Institute of Health and Welfare/Department of Health |
Source and reference attributes | |
Submitting organisation: | Australian Institute of Health and Welfare |
Reference documents: | Kidney Health Australia (2020) Chronic Kidney Disease (CKD) management in primary care, 4th edn, Kidney Health Australia, Melbourne, accessed 20 December 2021. |
Relational attributes | |
Related metadata references: | Supersedes Indigenous-specific primary health care: PI19a-Number of Indigenous regular clients with a selected chronic disease who have a kidney function test result within a specified level, June 2021 Indigenous, Standard 03/07/2022 |